In 2023, the import of heterocyclic compounds with N-hetero-atoms only to France stood at 390 million USD. Forecasts from 2024 to 2028 indicate a steady decline, starting from 383.36 million USD in 2024 and decreasing to 357.44 million USD by 2028. The year-on-year variation reveals a consistent negative trend, with an average annual decrease of approximately 1.38% over this period. The five-year CAGR estimates an overall decrease of around 1.7% annually in imports.
Future trends to watch for include shifts in the global supply chain, potential policy changes related to import tariffs or regulations, and the evolving demand for pharmaceutical and chemical products that utilize heterocyclic compounds. Monitoring technological advancements and industry innovations may also impact the import dynamics in the future.
